Literature DB >> 16542392

Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels.

S M Boekholdt1, O W Souverein, M W T Tanck, G K Hovingh, J A Kuivenhoven, R I G Peters, H Jansen, P M H Schiffers, E E van der Wall, P A Doevendans, P H Reitsma, A H Zwinderman, J J P Kastelein, J W Jukema.   

Abstract

It is assumed that the combined effects of multiple common genetic variants explain a large part of variation of high-density lipoprotein cholesterol (HDL-C) plasma levels, but little evidence exists to corroborate this assumption. It was our objective to study the contribution of multiple common genetic variants of HDL-C-related genes to variation of HDL-C plasma levels. A well-characterized cohort of 546 Caucasian men with documented coronary artery disease was genotyped for common functional variants in genes that control reverse cholesterol transport: ATP-binding cassette transporter A1, apolipoprotein A-I and apolipoprotein-E, cholesteryl ester transfer protein, hepatic lipase, lecithin : cholesterol-acyl transferase, lipoprotein lipase, and scavenger receptor class B type 1. Multivariate linear regression showed that these variants, in conjunction, explain 12.4% (95% confidence interval: 6.9-17.9%) of variation in HDL-C plasma levels. When the covariates smoking and body mass index were taken into account, the explained variation increased to 15.3% (9.4-21.2%), and when 10 two-way interactions were incorporated, this percentage rose to 25.2% (18.9-31.5%). This study supports the hypothesis that multiple, mildly penetrant, but highly prevalent genetic variants explain part of the variation of HDL-C plasma levels, albeit to a very modest extent. Multiple environmental and genetic influences on HDL-C plasma levels still have to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542392     DOI: 10.1111/j.1399-0004.2006.00578.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  16 in total

Review 1.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

2.  Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol.

Authors:  Latisha Love-Gregory; Richard Sherva; Lingwei Sun; Jon Wasson; Timothy Schappe; Alessandro Doria; D C Rao; Steven C Hunt; Samuel Klein; Rosalind J Neuman; M Alan Permutt; Nada A Abumrad
Journal:  Hum Mol Genet       Date:  2008-02-27       Impact factor: 6.150

3.  Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile.

Authors:  Latisha Love-Gregory; Richard Sherva; Timothy Schappe; Jian-Shen Qi; Jennifer McCrea; Samuel Klein; Margery A Connelly; Nada A Abumrad
Journal:  Hum Mol Genet       Date:  2010-10-08       Impact factor: 6.150

4.  Common Variants in 6 Lipid-Related Genes Discovered by High-Resolution DNA Melting Analysis and Their Association with Plasma Lipids.

Authors:  John F Carlquist; Jason T McKinney; Benjamin D Horne; Nicola J Camp; Lisa Cannon-Albright; Joseph B Muhlestein; Paul Hopkins; Jessica L Clarke; Chrissa P Mower; James J Park; Zachary P Nicholas; John A Huntinghouse; Jeffrey L Anderson
Journal:  J Clin Exp Cardiolog       Date:  2011-07-10

5.  Lipoprotein lipase gene sequencing and plasma lipid profile.

Authors:  Dilek Pirim; Xingbin Wang; Zaheda H Radwan; Vipavee Niemsiri; John E Hokanson; Richard F Hamman; M Michael Barmada; F Yesim Demirci; M Ilyas Kamboh
Journal:  J Lipid Res       Date:  2013-11-09       Impact factor: 5.922

Review 6.  Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

Authors:  Eva Boes; Stefan Coassin; Barbara Kollerits; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-11-17       Impact factor: 4.032

7.  Multiple genetic determinants of plasma lipid levels in Caribbean Hispanics.

Authors:  Yi-Chu Liao; Hsiu-Fen Lin; Tanja Rundek; Rong Cheng; Edward Hsi; Ralph L Sacco; Suh-Hang Hank Juo
Journal:  Clin Biochem       Date:  2007-11-29       Impact factor: 3.281

8.  Lipoprotein lipase HindIII polymorphism influences HDL-cholesterol levels in statin-treated patients with coronary artery disease.

Authors:  Martin Javorský; Daniela Gasperíková; Jozef Ukropec; Barbora Sedláková; Igor Riecanský; Ol'ga Krizanová; Elena Seböková; Martina Dobríková; Iwar Klimes; Ivan Tkác
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

9.  APOE genotype affects black-white responses of high-density lipoprotein cholesterol subspecies to aerobic exercise training.

Authors:  Thomas O Obisesan; Robert E Ferrell; Andrew P Goldberg; Dana A Phares; Tina J Ellis; James M Hagberg
Journal:  Metabolism       Date:  2008-12       Impact factor: 8.694

Review 10.  Lipoproteins, cholesterol homeostasis and cardiac health.

Authors:  Tyler F Daniels; Karen M Killinger; Jennifer J Michal; Raymond W Wright; Zhihua Jiang
Journal:  Int J Biol Sci       Date:  2009-06-29       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.